These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 21376305)

  • 1. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
    Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
    Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
    Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
    Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
    Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
    Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma.
    Ishida M; Egawa S; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Furukawa T; Unno M
    J Hepatobiliary Pancreat Surg; 2007; 14(5):522-5. PubMed ID: 17909725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
    Schmidt CM; White PB; Waters JA; Yiannoutsos CT; Cummings OW; Baker M; Howard TJ; Zyromski NJ; Nakeeb A; DeWitt JM; Akisik FM; Sherman S; Pitt HA; Lillemoe KD
    Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results.
    Tanno S; Nakano Y; Nishikawa T; Nakamura K; Sasajima J; Minoguchi M; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
    Gut; 2008 Mar; 57(3):339-43. PubMed ID: 17660227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.
    Bournet B; Kirzin S; Carrère N; Portier G; Otal P; Selves J; Musso C; Suc B; Moreau J; Fourtanier G; Pradère B; Lazorthes F; Escourrou J; Buscail L
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1211-7. PubMed ID: 19476563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas.
    Sugiyama M; Izumisato Y; Abe N; Masaki T; Mori T; Atomi Y
    Br J Surg; 2003 Oct; 90(10):1244-9. PubMed ID: 14515294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of total remnant pancreatectomy for ductal carcinoma after distal pancreatectomy for invasive intraductal papillary mucinous carcinoma].
    Okubo K; Hama N; Kobayashi S; Eguchi H; Akita H; Wada H; Kawamoto K; Marubashi S; Tanemura M; Umeshita K; Mori M; Doki Y; Nagano H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2140-2. PubMed ID: 23268003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic duct lavage cytology for the diagnosis of branch duct-type intraductal papillary mucinous neoplasm of the pancreas.
    Sai JK; Suyama M; Kubokawa Y; Watanabe S
    Pancreas; 2008 Mar; 36(2):216-7. PubMed ID: 18376321
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative evaluation of malignancy in intraductal papillary mucinous neoplasms of the pancreas, especially in relation to dysplastic epithelial changes.
    Mizumoto M; Honjo G; Kobashi Y; Nishimura S; Nakamura Y; Yoshimura T; Awane M; Kato Y; Furuyama H; Asao Y; Maeda H; Takakuwa H; Matsusue S
    Hepatogastroenterology; 2008; 55(82-83):704-7. PubMed ID: 18613438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.